Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.14 USD | -3.39% | -10.94% | -67.45% |
May. 14 | TRACON Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
May. 14 | Transcript : TRACON Pharmaceuticals, Inc., Q1 2024 Earnings Call, May 14, 2024 |
Business Summary
Number of employees: 17
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Therapeutics
100.0
%
| 0 | nan % | 12 | 100.0 % | - |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 0 | nan % | 12 | 100.0 % | - |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Charles Theuer
CEO | Chief Executive Officer | 60 | 06-06-30 |
Scott Brown
DFI | Director of Finance/CFO | 43 | 15-07-31 |
James L. Freddo
CTO | Chief Tech/Sci/R&D Officer | 69 | 20-04-30 |
Brenda Marczi
LAW | General Counsel | - | 21-07-19 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Martin Mattingly
BRD | Director/Board Member | 66 | 14-12-25 |
Director/Board Member | 54 | 20-03-18 | |
Stephen Worland
BRD | Director/Board Member | 66 | 15-02-24 |
Rainer Twiford
BRD | Director/Board Member | 71 | 08-08-31 |
William LaRue
BRD | Director/Board Member | 73 | 14-06-30 |
Charles Theuer
CEO | Chief Executive Officer | 60 | 06-06-30 |
Carol Lam
BRD | Director/Board Member | 64 | 21-10-11 |
Director/Board Member | 60 | 21-03-01 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 2,679,035 | 2,620,001 ( 97.80 %) | 0 | 97.80 % |
Company contact information
TRACON Pharmaceuticals, Inc.
4350 La Jolla Village Drive Suite 800
92122-1243, San Diego
+
http://www.traconpharma.comSector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-67.45% | 3.05M | |
+0.82% | 91.94B | |
-1.32% | 38.74B | |
-12.88% | 32.82B | |
+64.77% | 26.66B | |
-16.31% | 15.32B | |
-11.38% | 11.65B | |
+173.10% | 10.37B | |
-49.84% | 10.12B | |
+5.24% | 9.06B |
- Stock Market
- Equities
- TCON Stock
- Company TRACON Pharmaceuticals, Inc.